chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Parents report that Pt began with some symptoms the afternoon after he was vaccinated. He developed some spots that looked like "bug bites" similar to petechiae on his left leg and then his right leg was affected by the end of the evening. He ran a fever of 102.5 and Dad medicated him with Tylenol and his fever responded well. Friday both legs were affected with the dots and some swelling was apparent in both limbs. No fever was present. Saturday he had some continued swelling in both limbs and complained of pain when ambulating-his knees hurt. Monday the previous symptoms were still present. Spots were more like ecchymosis about the size of a dime on his body-trunk not affected, only arms and legs - no fever reported. Tuesday evening he complained to his mother that he had trouble urinating - upon examination she found his penis to be completely swollen, the scrotal area was not affected. Wednesday AM the parents decided to consult with their health care provider. She advised them to visit our public health clinic so we would be aware of Pt's condition and initiate a VAERS report then return to her for follow up care. Our office advised them to seek medical care ASAP and request lab work to determine what was affecting Pt. We discussed the possibility of some underlying condition that would possibly have been triggered by the vaccines. We told them we would be filing a report and would contact them to follow up on his condition. Labs were done, platelet ct <500. White ct WNL. 8/27/08 - Child was referred to pediatric specialist (hematology) at hospital per NP. To be seen there week of Aug 25-29 for consultation. Will report back to local practice regarding this pt. Child is much improved per mother's observation.
2 large red welps on left deltoid that are sore and warm to the touch where she received her PREVNAR 13 vaccine. She also felt a little shaky. Provider advised patient to take Benadryl OTC and if she has no improvement to start Augmentin Rx on Saturday 1/14/16. Instructed to go to the nearest emergency room should SOB develop.
7/23--7/27 33 y.o. male with past medical history of alcoholic cirrhosis complicated by hepatic encephalopathy who was transferred to ED from outside hospital on 07/23/22 with chief complaint of bleeding from venipuncture site and toe after trimming his nails. Patient was recently admitted for pneumonia and sepsis with a COVID positive test on 7/03 s/p monoclonal antibodies. During this visit, patient was diagnosed with bilateral pleural effusions and MRI showing psoas abscess and liver cysts. He was discharged on 07/21 with a 12 day course of ceftin and Flagyl. On 07/23, presented due to uncontrolled bleeding from his venipuncture site and toe where he was found to be thrombocytopenic with elevated coagulation parameters. Platelet infusion was started but was not completed due to patient becoming short of breath with associated edema requiring Lasix. Patient was transferred here for further management. CXR showed right perihilar opacity which may reflect pneumonia and trace left effusion. MRI showed likely psoas muscle hematoma, indeterminate medial left lobe lesion worrisome for malignancy, indeterminate anterior right lobe lesion, cirrhosis with findings of portal hypertension, splenomegaly, moderate caliber varices with patent portal vein, cholelithiasis with diffuse gallbladder wall thickening, and small pleural effusions with lung base atelectasis. US abdomen with similar findings. Repeat MRI characterized liver lesions as hemangiomas.  He was found to have significantly elevated INR with bleeding from venipuncture sites.  Patient was given 3 days 10 g vitamin K.  His INR continually decreased day by day and venipuncture bleeding ceased.  Respiratory atypical bacteria panel, legionella, and strep pneumoniae antigens were negative. Hepatology was consulted - patient does not meet criteria for further evaluation for liver transplant at this time. This was discussed by hepatology  team with the patient. We enquired hepatology about the EGD for variceal banding who recommended that it can be done as outpatient since there is no suspicion of active bleed. Also recommended that antibiotics prophylaxis was not indicated. Prior to discharge, we discussed this all with the patient. Patient was discharged in stable condition and instructed to follow-up with the specialists and PCP. All questions were answered.
approx 3wk p/vax pt devel pain in lt shoulder joint & pain w/arm movement;
Child was noted to have swollen and reddened, left upper thigh with painful reaction by infant. Infant taken to PMD. Right lower arm from hand to below elbow also seem to be swollen. Infant sent to ER.
in early AM on day following vax pt devel hives & itching; pt took DPH;
Pts arm was red, swollen, and hot around injection site. Pt saw PCP and PCP prescribed azithromycin, and MEDROL D.P.
After receiving the vaccine, I slept okay, the next morning about an hour after I woke up I had severe chills, body aches, and nausea. I had to go home from work due to these feelings. Eventually, developed into a fever. I went home and the chills and aches worsened. I could not get warm not matter how many layers or blankets I had. I took tylenol and fell asleep after several hours. When I woke up, I was profusely sweaty, my fever  broke. I was able to eat a small lunch and continued to lie down the whole day. My symptoms lessened and were more minimal 24 hours after. After going to sleep the second night, I felt back to normal upon wake up.
Rash covering entire abdomen, groin, back & buttocks appeared almost 48 hours after injection.  No itching or pain or fever.  Slight sore throat.  Resolved in 12 hours.
Nausea; Pain at the injection site; sore muscles in the upper back and shoulders; tiredness; This is a spontaneous report from a non-contactable consumer (patient). This 39-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL3247) via unspecified route of administration in the left arm on 18Feb2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (lot number EL3247) in the left arm on 28Jan2021 at 09:30 (at the age of 39-years-old) for COVID-19 immunisation. On 18Feb2021 at 22:00 the patient experienced nausea, pain at the injection site, sore muscle in the upper back and shoulders, and tiredness. The events were reported as non-serious and did not require hospitalization. No treatment was received for the adverse events. The clinical outcomes of nausea, pain at the injection site, sore muscles in the upper back and shoulders, and tiredness were recovered in Feb2021. It was also reported that since vaccination the patient was not tested for COVID-19.
Administered the vaccine to a patient who is 16 year-old; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered the vaccine to a patient who is 16 year-old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered the vaccine to a patient who is 16 year-old). On 11-Jan-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered the vaccine to a patient who is 16 year-old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Batch number of Dose 1 and 2 updated. On 30-Jul-2021: Race information and Ethnic group added
Knew 2 girls that didn't take their 2nd dose & died; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Knew 2 girls that didn't take their 2nd dose & died) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant product was not provided by the reporter  Treatment information was not provided  Company's comment: This is a spontaneous report concerning a female patient of unknown age and medical history. The reporter mentions that knew the patient and that she hadn't taken the second dose of the vaccine and died. The date of vaccination and manufacturer were not reported, nor was cause of death. No further information was disclosed. A query was raised requesting any information that can be provided to further elucidate this case.   This case was linked to MOD-2021-395659, MOD-2021-395672 (Patient Link).; Sender's Comments: This is a spontaneous report concerning a female patient of unknown age and medical history. The reporter mentions that knew the patient and that she hadn't taken the second dose of the vaccine and died. The date of vaccination and manufacturer were not reported, nor was cause of death. No further information was disclosed. A query was raised requesting any information that can be provided to further elucidate this case.; Reported Cause(s) of Death: Unknown cause of death
pt recv vax AUG96 & approx 3wk p/vax pt exp depression, which was out of character for pt;
Within the first few minutes after receiving the vaccine, the patient indicated that her tongue felt tingly. She denied any additional symptoms, but within the next few minutes she began to experience mild throat tightness, although the tingly tongue resolved. She denied DIB, SOB, wheezing, chest tightness, swollen tongue, racing pulse, or anxiety. She was given a dose of diphenhydramine 25 mg at 1119 and was reassessed frequently. Approximately 10-15 minutes after the  diphenhydramine, she verbalized that she was feeling some improvement of the throat tightness. She stated she had diphenhydramine at home and would take an additional 25 mg if her symptoms worsened again. She was also instructed to go to the ED if her symptoms rebounded.
Information has been received from a registered nurse concerning a female patient who on unspecified date was vaccinated with a second dose of GARDASIL (manufacturer unspecified) (lot # not reported). The patient told to to the nurse that 30 days after receiving the second dose of GARDASIL she developed canker sores in her mouth which turned into a bacterial infection that went to her gums. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
PEDIATRIC DOSE (10MCG) OF PFIZER WAS INADVERTENLY ADMINISTERED TO PT THEN THE CORRECT ADULT DOSE OF 30MCG WAS ADMINISTERED. NO ADVERSE EFFECTS WERE REPORTED.
Right arm became hot and aching, hurt all night. On the 28th of Sept, the pain went up my arm into my neck. The pain became very sensative. I figured it would subside in a few days.It did not. I've been in pain since the 27th of Sept. I'm scheduled to have a spinal injection of steroids in C6-7 on 11/11/2019 to knock out the enflamation.
Adult Hep A vaccine dose administered to 18 yr old instead of pediatric Hep A vaccine dose.
Red bump started, then a yellow crust formed at injection spots about an inch large.  Highly unusual reaction.  It's been two months and issue still there.  Possible exposure to unclean or infected office. (can provide photos of reaction)
I was coughing and my daughter who is a pharmacist urged me to test for COVID-19. I tested positive with a very faint line on an antigen test. My husband had already tested positive for COVID-19 so I had been wearing a mask. We were out of town at the time that we tested positive, so we isolated in a hotel until we could fly home. I called my doctor while still out of town who called in a prescription for PAXLOVID. My symptoms consisted of a cough, body aches, chills, and fatigue. My cough still persists, primarily at night but after around 2 days the majority of my symptoms went away and I tested negative as of Tuesday 07/19/2022.
mom took pt for 18 month check up & poss ear infection-MD noticed rt leg hard-red-tender w/pus @ center;
I felt severe shortness of breath and dyspnea on 3/30/21 at 3:30am, so I went to the ER and was diagnosed with pulmonary embolisms in both lungs and tachycardia. I was prescribed Eliquis. I am still experiencing shortness of breath today 4/13/21, but it has improved since the onset of symptoms.
Headache, Myalgia, Fever, Angina, Shortness of Breath Narrative:
I received this dose on 9/16/22 and about two days after I received this dose, I started swelling in my lower extremities  Then, on Tuesday, it was all over my body, but my legs is where it was showing the most. It hasn't gotten any better. It pretty much has stayed the same. The prescribed Cefuroxime because they thought I had a lingering UTI, but the culture came back negative and they sent me a text saying to stop taking the antibiotic.
This spontaneous report as received from an other health professional refers to a 2 year old patient. On 17-JUL-2014 the patient was vaccinated with M-M-R II (HSA, lot # J015503, EXP 05-DEC-2015 dose and route not reported) which was stored improperly. There was no adverse effect reported. This is one of several reports received from the same source. Additional information is not expected.
Injection site is itchy; Injection site is painful; Injection site is red; Injection site is red; Injection site is swollen; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PRURITUS (Injection site is itchy), the first episode of INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PAIN (Injection site is painful) and the second episode of INJECTION SITE ERYTHEMA (Injection site is red) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced the first episode of INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen) and the second episode of INJECTION SITE ERYTHEMA (Injection site is red). On 30-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Injection site is itchy) and INJECTION SITE PAIN (Injection site is painful). At the time of the report, INJECTION SITE PRURITUS (Injection site is itchy), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PAIN (Injection site is painful) and the last episode of INJECTION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Pt noted heat and swelling on left arm where injection was given. Pt broke out in a rash on left side of face, chest and back. She took Tylenol and went to bed. The day of report she noted increased swelling and was advised to see private MD.
Pt had a syncopal event Vitals: 98/88, 72, 100% Pt given juice. Pt stable and released from the vaccination site @17:00.
Heart beats skipping after eating or during exercise. I have never experienced this before and it has nearly complete stopped after about a month
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Aug2021 at 08:00 as dose 2, single (Lot number: EW0167) at the age of 62 years, in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Pre-diabetes" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; MELOXICAM; DULOXETINE. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0164, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 10Aug2021, when the patient was 62-year-old, for Covid-19 Immunization. The following information was reported: MUSCLE SWELLING (disability), TENDON RUPTURE (disability) all with onset 20Jan2022 at 04:00, outcome "not recovered" and all described as "Torn deltoid tendon, resulting in "Popeye arm"". The event "torn deltoid tendon, resulting in "Popeye arm"" required physician office visit. Therapeutic measures were not taken as a result of muscle swelling, and tendon rupture. Clinical course: No other Vaccine in four weeks. Patient had no known allergies. Patient did not had Covid prior vaccination and not Covid tested post vaccination.
On 4/1/2021 Patient had at least one seizure at home and upon arriving at the ER/hospital had a severe seizure.  She was admitted to the hospital for treatment and was in the intensive care unit for about 9 days.  She was given seizure medicine along with other fluids to keep her hydrated and fed.  Multiple EEGs were taken to track the electrical activity within her brain - which even with high doses of medication was very active.  A spinal tap was done to test for infection and no viruses were found.  An MRI was completed to identify what part of the brain was being impacted.   The area of the brain that was impacted was the side and the images showed it was very inflamed.  She has since been moved to a physical therapy facility to try to help her improve.  At this time, she still needs assistance for all activities and would not be able to return home due to the level of care she needs.  Her current diagnosis is autoimmune encephalitis.  She has never had seizures before and this one began about two weeks after receiving her first dose of the COVID-19 shot.  She has been unable to receive her second shot due to being in the hospital and physical therapy facility.  Due to the timing of the seizure event, we are very concerned with her receiving her second shot as well.
I admisteredd vaccines Menactra and Bexsero to patient today about 4:25pm and patient seemed fine. Patient and mother were standing and Mom asked me to change the time to late afternoon appt due to her work schedule, I agreed and proceeded to go back to my seat and change appointment. Within a few minutes I heard a scuffle sound and someone called my name to help. I then ran to help patient get up, he stated he felt dizzy and it went dark as he fainted. I called for a Nurse to come and help that a pt had fainted. Started around 4:35pm. Came back after putting away medications. Pt on ground by the sink. Mom on one side MA and  MA on other side. MA states pt fell and knows where he is, his name and birthdate. Mom stated he hit his head and needs neuro assessment. Pt stated he blacked out and found himself sitting on the floor. RN 1 and RN 2 came into IZ room. RN placed pulse on finger and it was 98 O2Sat and Pulse 48. RN does Neuro assessment and reports all is good. RN goes to do closing. Pt given water. MA calls NP and has her come to assess pt because he just saw her in clinic and had two shots ordered. Pt reports head does not hurt. Pt slightly shaking with hands. Informed to get cold pack to place on back of neck. Obtain cold pack and placed on back of pt's neck. NP came and informed that pt needs BP taken. RN came into IZ room to help traige. Obtain BP 150/62. Pt reported that right temple he hit on sharps box. NP completed neruo asessment. NP reported PERLA and good assessment. Pt reported had not eaten anything since 10am. It is now 5:03pm pt's blood sugar was 112. Retook pt's BP 129/58, Pulse 62 and 99 O2Sat. HR 62. Pt feels better. Able to sit in chair and not feel dizzy and reports no spots or stars. NP informed mom and pt of home and UC precautions. Mom verbalized understanding. Pt and mom walked out of clinic on their own.
1/6/22 1 10:00a - pain at injection site during vaccine injection and after needle was removed. Continuous ache up to current time of this report. Painful to the touch, injection site very warm. 2p - body aches & Headaches 7p - Body Aches in body increase in the level of pain, half dollar ring around injection site and upper arm swollen. Continued fatigue. 11p - Body aches getting severe across upper shoulders and back from left arm as well as headache pain increases. 11/7/22 1a - Cannot lay on arm at all, painful joints all over body, chills, can not sleep due to pain in body, severe headache. 5a - After not sleeping all night due to the pain in my body and headache, it took me a while to get out of bed with the pain in my joints. 6a - headache, body aches/pain, red and swollen at injection site painful to the touch, fatigue/drained, arm/shoulder/neckpain/back pain specific.
'localized' allergic reactions; throat and mouth were tingly and swelling; throat and mouth were tingly and swelling; throat and mouth were tingly and swelling; throat and mouth were tingly and swelling; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program, COVAX US Support. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) intramuscular, administered in left upper arm on 26Mar2021 (Batch/Lot Number: EP6955) (at the age of 42-years-old) as dose 1, single for COVID-19 immunisation. Vaccination facility type was pharmacy/drugstore. Medical history included asthma and allergy. Concomitant medications included budesonide (PULMICORT); albuterol [salbutamol] and verapamil, all for an unspecified indications, on unspecified dates; and loratadine (CLARITIN) for allergy on unspecified date. The patient reported that she got allergic reactions, a 'localized' allergic reactions when she got the first dose on 26Mar2021. The patient stated that at the pharmacy, they sent her in an ambulance to the hospital, and her reaction was her throat and mouth were tingly and swelling so they sent her in an ambulance to the hospital and ended up taking Benadryl. The patient is no longer experiencing the allergic reaction. The patient was not hospitalized, only stayed in an emergency room. The patient had no prior vaccination within 4 weeks. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.